| scholarly article | Q13442814 |
| P50 | author | Manabu Wada | Q48534189 |
| P2093 | author name string | Shigeki Arawaka | |
| Takeo Kato | |||
| Toru Kawanami | |||
| Hiroyasu Sato | |||
| Shingo Koyama | |||
| Susumu Hara | |||
| Masahiro Sakamoto | |||
| Saori Goto | |||
| Hiroki Karube | |||
| Keiji Kurita | |||
| Chang-Hong Ren | |||
| P2860 | cites work | Mutation in the alpha-synuclein gene identified in families with Parkinson's disease | Q27860459 |
| alpha-Synuclein locus triplication causes Parkinson's disease | Q27860533 | ||
| α-Synuclein in Lewy bodies | Q27860680 | ||
| The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia | Q29547174 | ||
| AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease | Q29547175 | ||
| Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders | Q29614754 | ||
| Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes | Q29617606 | ||
| Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice | Q30476254 | ||
| alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins | Q33929879 | ||
| A broken alpha -helix in folded alpha -Synuclein | Q34177224 | ||
| Selective Insolubility of α-Synuclein in Human Lewy Body Diseases Is Recapitulated in a Transgenic Mouse Model | Q35747138 | ||
| Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery | Q36610346 | ||
| The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease. | Q40234774 | ||
| The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease | Q40669171 | ||
| Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. | Q43735119 | ||
| Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein | Q43866953 | ||
| Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease | Q46593989 | ||
| Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein | Q46768370 | ||
| The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease | Q47924844 | ||
| Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines | Q48214340 | ||
| Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease | Q48353748 | ||
| Synthetic filaments assembled from C‐terminally truncated α‐synuclein | Q48360396 | ||
| Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. | Q48384247 | ||
| Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein | Q48581887 | ||
| Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. | Q48586171 | ||
| Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. | Q52165843 | ||
| Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo. | Q52678048 | ||
| P433 | issue | 25-26 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Synuclein | Q24767155 |
| fatty acid | Q61476 | ||
| P304 | page(s) | 3693-3700 | |
| P577 | publication date | 2008-10-09 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | N-terminal region of alpha-synuclein is essential for the fatty acid-induced oligomerization of the molecules | |
| P478 | volume | 582 |
| Q35687279 | A comprehensive study of repetitive transcranial magnetic stimulation in Parkinson's disease. |
| Q42322220 | Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome |
| Q38759482 | Alpha-Synuclein as a Biomarker for Parkinson's Disease |
| Q34774324 | Alpha-synuclein function and dysfunction on cellular membranes |
| Q35155985 | Alpha-synuclein functions in the nucleus to protect against hydroxyurea-induced replication stress in yeast |
| Q35903976 | Alterations in Lipid and Inositol Metabolisms in Two Dopaminergic Disorders |
| Q58773578 | Cholesterol secosterol aldehyde adduction and aggregation of Cu,Zn-superoxide dismutase: Potential implications in ALS |
| Q38898891 | Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation |
| Q64263610 | Intrinsically disordered proteins in synaptic vesicle trafficking and release |
| Q64074236 | Lipids at the Crossroad of α-Synuclein Function and Dysfunction: Biological and Pathological Implications |
| Q57636158 | Membranes as modulators of amyloid protein misfolding and target of toxicity |
| Q33844949 | Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson's Disease |
| Q33715640 | Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies |
| Q92465171 | Parkinson's disease: proteinopathy or lipidopathy? |
| Q39642185 | Phosphorylated α-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent Manner |
| Q38834595 | Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spaces |
| Q36887384 | Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner |
| Q38672388 | The Golgi-localized, gamma ear-containing, ARF-binding (GGA) protein family alters alpha synuclein (α-syn) oligomerization and secretion |
| Q39410832 | The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease |
| Q61804251 | The Role of Lipids in Parkinson's Disease |
| Q34972009 | The many faces of α-synuclein: from structure and toxicity to therapeutic target |
| Q64866429 | α-Synuclein and Polyunsaturated Fatty Acids: Molecular Basis of the Interaction and Implication in Neurodegeneration |
| Q37176108 | γ-synuclein is a novel player in the control of body lipid metabolism |
Search more.